Background: Alzheimer's disease is a progressive neurodegenerative disorder that mainly affects the brain resulting gradual decline in a cognitive function, memory impairment, alterations in behavior, potentially resulting in the inability to engage in a conversation and react to the surroundings. Corpus callosum (CC) is the principal white fabric matter present in the center of the brain that connects the left and right cerebral hemispheres. Neurodegenerative diseases can impact the size and structure of the CC, leading to its atrophy and dysfunction. This study aims to detect the CC in a given Structural MRI and classify Early Mild Cognitive Impairment (EMCI) vs. Late Mild Cognitive Impairment (LMCI). This study introduces the prospect of utilizing a YOLOv5-based framework for CC detection, aiming to distinguish between individuals with EMCI and LMCI. In addition, we have also interpreted our results using Eigen CAM.
Method: In this study, we proposed a Fine-tuned Yolov5 based object detection model for detecting CC and classifying EMCI vs LMCI. Unlike previous studies that focused solely on CC (texture analysis) for detecting MCI, our method considers both CC and the surrounding context for better EMCI vs LMCI classification. In our approach, we used MRI slices along with the corpus callosum area, enclosed in a bounding box tightly fitted to the CC coordinates. The YOLOv5 model consists of three parts: the backbone extracts features, the neck combines features at different scales, and the head makes final predictions. In this case, the object of interest for the model is the CC to classify EMCI vs LMCI.
Result: The dataset used in this study was obtained from ADNI and consists of total 100 subjects, evenly distributed between EMCI vs LCMI. The dataset was partitioned into 80% for training and 20% for testing. We achieved 97% accuracy on test dataset.
Conclusion: This study demonstrates YOLOv5's efficiency in CC detection for EMCI and LMCI classification. The classification results are further interpreted using Eigen CAM. In future Fine-tunning the model parameters and exploring other CAM varients can improve the results.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.087878 | DOI Listing |
Background: Mild Cognitive Impairment (MCI) represents an intermediate stage between normal age-related cognitive decline and more severe degenerative conditions such as Alzheimer's disease. Understanding the differences between Early-MCI (EMCI) and Late-MCI (LMCI) is crucial to facilitate early diagnosis and future clinical interventions. This study employed free-water diffusion tensor imaging (FW-DTI) to explore the differences in white matter alterations between EMCI and LMCI.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Centre for Brain Research (CBR), Indian Institute of Science, Bengaluru, Karnataka, India.
Background: Alzheimer's disease is a progressive neurodegenerative disorder that mainly affects the brain resulting gradual decline in a cognitive function, memory impairment, alterations in behavior, potentially resulting in the inability to engage in a conversation and react to the surroundings. Corpus callosum (CC) is the principal white fabric matter present in the center of the brain that connects the left and right cerebral hemispheres. Neurodegenerative diseases can impact the size and structure of the CC, leading to its atrophy and dysfunction.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
The Clinical Hospital of Chengdu Brain Science Institute, MOE Key Lab for Neuroinformation, School of Life Science and Technology, University of Electronic Science and Technology of China, Chengdu, China.
Background: Light therapy has emerged as an effective method for Alzheimer's disease (AD). However, the efficacy on cognitive function in Alzheimer's continuum and factors affecting efficacy have not been established. The study aimed to evaluate the efficacy of 500 nm blue-green light therapy on cognitive function for Alzheimer's continuum, and the main factors affecting light therapy efficacy were analyzed.
View Article and Find Full Text PDFBackground: Alzheimer's Disease (AD) presents a major health challenge, with complex and variable neurodegenerative progression. Traditional neuroimaging falls short in fully capturing this heterogeneity. Our study addresses this gap by applying an Event-Based Model (EBM) to Alzheimer's Disease Neuroimaging Initiative (ADNI) Positron Emission Tomography (PET) data, enriched with connectomics data.
View Article and Find Full Text PDFBackground: Alzheimer's disease (AD) is a neurodegenerative disorder characterised by cognitive decline and progressive deterioration of brain function. Recent research has suggested a complex interplay between AD and bone health, with individuals affected by AD exhibiting an increased propensity for fractures and falls. Our preclinical studies in PSEN, MAPT P301 S and FDD mice have shown sex-dependent changes in the bone in AD mice, compared to their age-matched wild type mice.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!